You have not yet voted on this site If you have already visited the site, please help us classify the good from the bad by voting on this site. One excellent use of this calendar is to tweet at Neil deGrasse Tyson a few days ahead of each event, to give him a heads up. How else will he know. Biotech Industry, Biotech News, Biotechnology Articles Fierce. Biotech. The deal gives Roivant, Axovants parent company, another part developed, unloved drug to try to turn into a star. Gilead boosted oncology chief Riva to EVP, Moderna lost three top R D officials, Bayer poached Pfizers consumer marketing vet and more. Mebias presented rat data showing its mu opioid drugs could become a weapon in the scramble to combat the opioid epidemic. Johnson Johnson has notched a deal with Arcturus Therapeutics to help with its new focus on hepatitis B. The study linked synthetic oral endocannabinoid mimetic anabasum to a statistically significant drop on a skin disease scale. Microbiome startup AOBiome Therapeutics has seen positive data from its phase 2b trial in acne. People are turning down jobs at Astra. Zeneca because of uncertainty about their right to stay in the United Kingdom after Brexit. The mid development tweaks have the blessing of regulators, enabling uni. Qure to start a pivotal trial next year with its fast track statuses intact. Forge Therapeutics and Evotec have launched a discovery platform to develop novel antibiotics targeting metalloenzymes. Opti. Scan Biomedical scored an FDA nod for its bedside device that continuously monitors ICU patients glucose levels.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |